Literature DB >> 4745237

Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972.

P E Mertens, R Patton, J J Baum, T P Monath.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4745237     DOI: 10.4269/ajtmh.1973.22.780

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  20 in total

1.  Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.

Authors:  D G Bausch; P E Rollin; A H Demby; M Coulibaly; J Kanu; A S Conteh; K D Wagoner; L K McMullan; M D Bowen; C J Peters; T G Ksiazek
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Experimental Lassa virus infection in the squirrel monkey.

Authors:  D H Walker; H Wulff; F A Murphy
Journal:  Am J Pathol       Date:  1975-08       Impact factor: 4.307

3.  Lassa immune serum.

Authors:  A J Clayton
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

Review 4.  Occupational hazards in hospitals: risk of infection.

Authors:  J J Gestal
Journal:  Br J Ind Med       Date:  1987-07

5.  Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team.

Authors: 
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

6.  Diagnosis of Lassa fever and the isolation and management of patients.

Authors:  T P Monath; J Casals
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

7.  A serological survey of Lassa fever in Liberia.

Authors:  A Bloch
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

Review 8.  Lassa fever: review of epidemiology and epizootiology.

Authors:  T P Monath
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

9.  Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.

Authors:  Danny A Asogun; Donatus I Adomeh; Jacqueline Ehimuan; Ikponmwonsa Odia; Meike Hass; Martin Gabriel; Stephan Olschläger; Beate Becker-Ziaja; Onikepe Folarin; Eric Phelan; Philomena E Ehiane; Veritas E Ifeh; Eghosasere A Uyigue; Yemisi T Oladapo; Ekene B Muoebonam; Osagie Osunde; Andrew Dongo; Peter O Okokhere; Sylvanus A Okogbenin; Mojeed Momoh; Sylvester O Alikah; Odigie C Akhuemokhan; Peter Imomeh; Maxy A C Odike; Stephen Gire; Kristian Andersen; Pardis C Sabeti; Christian T Happi; George O Akpede; Stephan Günther
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

10.  Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.

Authors:  Kathleen A Cashman; Mark A Smith; Nancy A Twenhafel; Ryan A Larson; Kevin F Jones; Robert D Allen; Dongcheng Dai; Jarasvech Chinsangaram; Tove' C Bolken; Dennis E Hruby; Sean M Amberg; Lisa E Hensley; Mary C Guttieri
Journal:  Antiviral Res       Date:  2011-03-01       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.